Paliperidone 3-monthly prolonged release injection (Trevicta®)

 In Mental Health, Pharmacy Information

A 3-monthly prolonged release injection of paliperidone has become available (Trevicta®)

Paliperidone is an antipsychotic medicine used for schizophrenia and psychotic or manic symptoms. It is available as a modified-release tablet (Invega®). It is also available for maintenance treatment as a prolonged release 1-monthly injections (Xeplion®).

Trevicta® is licensed for use with patients who are already clinically stable on Xeplion®

It is essential for patient safety that the 1-monthly and 3-monthly injections are prescribed and administered correctly. The only clinical advantage in using Trevicta® is the reduced frequency of administration. There are no cost advantages, as the price is pro rata the same.

Further details are available from the manufacturer’s summary of product characteristics (SPC).

Recent Posts

Start typing and press Enter to search

Kwells